Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A; German Hodgkin's Lymphoma Study Group. Behringer K, et al. Among authors: reineke t. J Clin Oncol. 2005 Oct 20;23(30):7555-64. doi: 10.1200/JCO.2005.08.138. J Clin Oncol. 2005. PMID: 16234521
Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Nogová L, Reineke T, Brillant C, Sieniawski M, Rüdiger T, Josting A, Bredenfeld H, Skripnitchenko R, Müller RP, Müller-Hermelink HK, Diehl V, Engert A; German Hodgkin Study Group. Nogová L, et al. Among authors: reineke t. J Clin Oncol. 2008 Jan 20;26(3):434-9. doi: 10.1200/JCO.2007.11.8869. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086799
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group. Sieber M, et al. Among authors: reineke t. J Clin Oncol. 2003 May 1;21(9):1734-9. doi: 10.1200/JCO.2003.06.028. J Clin Oncol. 2003. PMID: 12721249 Clinical Trial.
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).
Nogová L, Reineke T, Eich HT, Josting A, Müller-Hermelink HK, Wingbermühle K, Brillant C, Gossmann A, Oertel J, Bollen MV, Müller RP, Diehl V, Engert A. Nogová L, et al. Among authors: reineke t. Ann Oncol. 2005 Oct;16(10):1683-7. doi: 10.1093/annonc/mdi323. Epub 2005 Aug 10. Ann Oncol. 2005. PMID: 16093276 Free article.
Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma.
Sieniawski M, Staak O, Glossmann JP, Reineke T, Scheuss H, Diehl V, Engert A, Josting A. Sieniawski M, et al. Among authors: reineke t. Ann Hematol. 2007 Feb;86(2):107-15. doi: 10.1007/s00277-006-0210-5. Epub 2006 Nov 14. Ann Hematol. 2007. PMID: 17103169 Clinical Trial.
209 results